UTI Small Cap Fund

A Small Cap Fund scheme from UTI Mutual Fund. Figures below are for the Direct · Growth plan (ISIN INF789F1AUQ1).

NAV ₹29.2429 on 16 November 2026.

Expense ratio

Total expense ratio 1.05% a year for the Direct · Growth plan, as AMFI published it on 29 October 2026: base expense ratio 0.73%, brokerage 0.06%, transaction costs 0.00%, statutory levies including GST 0.26%.

Returns and risk

PeriodReturn a yearVolatilityWorst fallSharpeSortino
1 year3.8%17.1%-16.7%-0.19-0.19
3 years12.4%17.0%-22.3%0.320.29
5 years13.2%16.1%-22.3%0.390.34

Too little NAV history for the 10-year figures.

Category rank: 17th of 27 Direct-Growth funds in Small Cap Fund, by 3-year Sortino ratio.

Largest holdings

Top 10 (September 2026 disclosure). Company shares make up 94.3% of the portfolio.

  1. NET CURRENT ASSETS (cash) — 5.68%
  2. Acutaas Chemicals Limited — 2.52%
  3. Navin Fluorine International Limited — 2.50%
  4. Karur Vysya Bank Limited — 2.41%
  5. City Union Bank Limited — 1.89%
  6. Caplin Point Laboratories Limited — 1.87%
  7. Ujjivan Small Finance Bank Limited — 1.86%
  8. Marksans Pharma Limited — 1.83%
  9. The Great Eastern Shipping Company Limited — 1.81%
  10. Affle 3i Limited — 1.71%

Plans

Other funds in Small Cap Fund

All 37 funds in Small Cap Fund · Compare this fund with another

Past returns are history, not a forecast. XIRRO describes funds and portfolios; it is information, not investment advice.